CEBPA and acute myeloid leukemia: On the other hand, CEBPA may also act as an oncogene in AML, since it was shown to inhibit both the intrinsic and extrinsic pathways of apoptosis by epigenetically activating the expression of two antiapoptotic genes, bcl2 and FLIP, respectively [28].